HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis.

AbstractBACKGROUND/AIMS:
To determine dynamics of albumin in plasma and ascitic fluid of patients with cirrhosis.
METHODS:
Forty-seven patients were classified in four groups: I--patients without fluid retention; II--patients with ascites not resistant to subsequent diuretic treatment; III--recompensated patients during diuretic treatment; and IV--patients with diuretic-resistant ascites. Transvascular and transperitoneal albumin transports were quantified by 131I-/125I-labelled human albumin.
RESULTS:
TER(P) (i.e. the fraction of intravascular albumin (IVM) passing from plasma into the interstitial space per hour) was increased in all groups. In group IV patients the transport rate of albumin from plasma into the ascitic fluid (TER(PA)) was significantly higher than the transport rate from the ascitic fluid back into the plasma: TER(AP) (0.45 vs. 0.26% IVM/h, P < 0.002). In group II patients TER(PA) was similar to TER(AP) (0.27 vs. 0.25% IVM/h, ns). A direct correlation was found between TER(PA) and TER(AP) in both groups of patients (r = 0.78, P < 0.001).
CONCLUSION:
In non-resistant ascites, there is a steady state between the transport of albumin into the peritoneal cavity and back into the plasma, but in resistant ascites the former transport is elevated. Thus, local factors may be important to treatment of ascites.
AuthorsJ H Henriksen, O Siemssen, J J Krintel, A Malchow-Møller, F Bendtsen, H Ring-Larsen
JournalJournal of hepatology (J Hepatol) Vol. 34 Issue 1 Pg. 53-60 (Jan 2001) ISSN: 0168-8278 [Print] Netherlands
PMID11211908 (Publication Type: Journal Article)
Chemical References
  • Serum Albumin
Topics
  • Adult
  • Aged
  • Ascitic Fluid (metabolism)
  • Biological Transport
  • Female
  • Hemodynamics
  • Humans
  • Liver Cirrhosis (metabolism)
  • Male
  • Middle Aged
  • Serum Albumin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: